Evidence map›Paper›PMID 41706251›Full record

ArticleEndocrine pathology2026

From Tissue Architecture To Genetic Signature: Artificial intelligence-based Analysis of Reticulin Framework and Clinical Variables Predicts Molecular Cluster in Paragangliomas.

Eleonora Duregon, Mirko Parasiliti-Caprino, Giulia Orlando, Anna Paola Ferrero, Martina Bollati, Rute Pedrosa, Darshan Kumar, Giuseppe Giraudo, Barbara Pasini, Ezio Ghigo and 4 more

Abstract read
In one paragraph

Article in Endocrine pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Eleonora DuregonDepartment of Oncology, University of Turin, Turin, Orbassano, Italy. eleonora.duregon@unito.it.
Mirko Parasiliti-CaprinoArterial Hypertension and Cardiovascular Endocrinology Laboratory, Division of Endocrinology, Diabetes and Metabolism, City of Health and Sciences University Hospital, Turin, Italy.
Giulia OrlandoDepartment of Oncology, University of Turin, Turin, Orbassano, Italy.
Anna Paola FerreroDepartment of Medical Science, University of Turin, Turin, Italy.
Martina BollatiArterial Hypertension and Cardiovascular Endocrinology Laboratory, Division of Endocrinology, Diabetes and Metabolism, City of Health and Sciences University Hospital, Turin, Italy.
Rute PedrosaAiforia Technologies Plc, Helsinki, Finland.
Darshan KumarAiforia Technologies Plc, Helsinki, Finland.
Giuseppe GiraudoDivision of Surgery, Department of General and Specialized Surgery, City of Health and Sciences University Hospital, Turin, Italy.
Barbara PasiniDivision of Medical Genetics, City of Health and Sciences University Hospital, Turin, Italy.
Ezio GhigoArterial Hypertension and Cardiovascular Endocrinology Laboratory, Division of Endocrinology, Diabetes and Metabolism, City of Health and Sciences University Hospital, Turin, Italy.
Emanuela ArvatDepartment of Medical Science, University of Turin, Turin, Italy.
Marco VolanteDepartment of Oncology, University of Turin, Turin, Orbassano, Italy.
Mauro MaccarioArterial Hypertension and Cardiovascular Endocrinology Laboratory, Division of Endocrinology, Diabetes and Metabolism, City of Health and Sciences University Hospital, Turin, Italy.
Mauro PapottiDepartment of Oncology, University of Turin, Turin, Orbassano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paragangliomas (PGLs), encompassing pheochromocytomas and extra-adrenal paragangliomas, are genetically heterogeneous non-epithelial neuroendocrine neoplasms that segregate into molecular clusters with distinct biological and clinical behavior. Architectural correlates of genotype have not been systematically investigated. This study aimed to assess the reticulin framework as a potential morphologic structural surrogate of molecular background and to introduce a novel deep learning model for its spatially resolved quantitative analysis and genotype prediction. A total of 104 adrenal and extra-adrenal PGLs with complete clinical, pathological, and genetic data were retrospectively analyzed. Reticulin stain was evaluated qualitatively and quantitatively using a supervised convolutional neural network trained on expert-annotated reticulin-stained whole-slide images (WSIs) to map and quantify areas of intact framework and very small nest patterns. Two bias-reduced logistic regression models (Firth’s method) were developed to predict germline cluster 1 genotype, each combining clinical variables (age, tumor size, extra-adrenal presentation) with one artificial intelligence (AI)-derived morphometric feature-percentage of intact framework (Model-INTACT) or very small nests (Model-VSN). PGLs harboring germline cluster 1 variants occurred at a younger age, were larger, more frequently extra-adrenal, and showed significant enrichment of intact reticulin and very small nest patterns compared with cases harboring germline cluster 2 variants and sporadic cases. The supervised AI model accurately mapped and quantified these architectural features across the WSIs. Predictive models integrating AI-derived morphometrics with clinical variables achieved excellent discrimination for germline cluster 1 genotype (AUC 0.981 for Model-INTACT; AUC 0.990 for Model-VSN). Preservation of the reticulin framework, particularly with very small nests, represents a histoarchitectural correlate of pseudohypoxic PGLs. Integration of AI-based morphometric descriptors with clinical parameters enables reliable pre-test prediction of germline cluster 1 genotype, bridging conventional histopathology and molecular classification.

Indexed as

Adrenal Gland NeoplasmsArtificial IntelligenceParagangliomaReticulinAdultConvolutional Neural NetworksDeep LearningFemaleGenotypeHumansMaleMiddle AgedRetrospective StudiesReticulinArtificial intelligence-based morphometric analysisComputational pathologyMolecular clustersParagangliomaReticulin framework

Identifiers

PMID41706251
PMCPMC12916514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.